Bibliography
- Stanton T , ReidJL. Fixed dose combination therapy in the treatment of hypertension. J. Hum. Hypertens., 16(2), 75–78 (2002).
- Neutel JM . Metabolic manifestations of low-dose diuretics. Am. J. Med., 101, 71S–82S (1996).
- Holmer SR , HenseHW, DanserAH, MayerB, RieggerGA, SchunkertH. β adrenergic blockers lower renin in patients treated with ACE inhibitors and diuretics. Heart, 80, 45–48 (1998).
- Ignarro LI . Experimental evidences of nitric oxide-dependent vasodilatory activity of nebivolol, a third generation β-blocker. Blood Press Suppl., 13(1), 2–16 (2004).
- Ceron CS , CastroMM, RizziEet al. Spironolactone and hydrochlorthiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension. Br. J. Pharmacol. , 160, 77–87 (2010).
- Guerrero E , VocesF, ArdanazN, MonteroMJ, ArévaloM, SevillaMA. Long-term treatment with nebivolol improves arterial reactivity and reduces ventricular hypertrophy in spontaneously hypertensive rats. J. Cardiovasc. Pharmacol., 42(3), 348–355 (2003).
- Malacco E . Nebivolol/hydrochlorthiazide a new fixed-dose combination for effective simplified antihypertensive therapy. High Blood Press. Cardiovasc. Rev., 15, 75–84 (2008).
- Fredline V , KovacsEM, TaylorPJ, JohnsonAG. Measurement of plasma renin activity with use of HPLC-electrospray-tandem mass spectrometry. Clin. Chem., 45, 659–664 (1999).
- Cockcroft JR , ChowienczykPJ, BrettSEet al. Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism. J. Pharmacol. Exp. Ther. , 274, 1067–1071 (1995).
- Zanchetti A . Clinical pharmacodynamics of nebivolol: new evidences of nitric oxide-mediated vasodilating activity and peculiar haemodynamic properties in hypertensive patients. Blood Press., 13(1), 17–32 (2004).
- Mason R , KubantR, JacobRF, WalterMF, BoychuckB, MalinskiT. Effect of nebivolol on endothelial nitric oxide and peroxynitrite release in hypertensive animals: role of antioxidant activity. J. Cardiovasc. Pharmacol., 48, 862–869 (2006).
- Ignarro LI . Different pharmacological properties of two enantiomers in a unique β-blocker, nebivolol. Cardiovasc. Ther., 26, 119–134 (2008).
- Brosnan MJ . One step beyond: glutathione peroxidase and endothelial dysfunction. Hypertension, 51, 825–826 (2008).
- Jessup JA , BrosnihanKB, GallagherPE, ChappellMC, FerrarioCM. Differential effect of low dose thiazides on renin angiotensin system in genetically hypertensive and normotensive rats. J. Am. Soc. Hypertens., 2, 106–115 (2008).
- Zhu Z , ZhuS, LiuD, CaoT, WangL, TepelM. Thiazide-like diuretics attenuate agonist-induced vasoconstriction by calcium desensitization linked to Rho kinase. Hypertension, 45, 233–239, (2005).
- Freis ED . How diuretics lower blood pressure. Am. Heart J., 106, 185–187 (1983).
- Birkenhager WH . Diuresis and blood pressure reduction: physiologic aspects. J. Hypertens., 8(2S), 3–7 (1990).
- Chan PS , RonsbergMA, CervoniP. Studies on the mechanism of the synergistic antihypertensive activity of captopril and hydrochlorothiazide following acute administration in spontaneously hypertensive rats. Clin. Exp. Hypert. A, 4(6), 1019–1026 (1982).
- Fortepiani LA , OrtizMC, AtuchaNM, Garcia-EstanJ. Nebivolol ameliorates nitric oxide deficient hypertension. ScientificWorldJournal, 2, 1676–1684 (2002).
- Henning R , KarlbergBE, Odar-CederlöfIet al. Timolol and hydrochlorothiazide-amiloride in primary hypertension. Clin. Pharmacol. Ther. , 28(6), 707–714 (1980).
- Varagic J , AhmadS, BrosnihanKBet al. Salt-induced renal injury in spontaneously hypertensive rats: effect of nebivolol. Nephrology , 32, 557–566, (2010).
- Brixius K , BundkirchenA, BolckB, MehlhornU, SchwingerR.H. Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium. Br. J. Pharmacol., 133, 1330–1338 (2001).